Exploratory Pilot Study of Circulating Biomarkers in Metastatic Renal Cell Carcinoma

Exploratory Pilot Study of Circulating Biomarkers in Metastatic Renal Cell Carcinoma

With the introduction of immune checkpoint inhibitors (ICIs) and next-generation vascular endothelial growth factor receptor–tyrosine kinase inhibitors (VEGFR–TKIs), the survival of patients with advanced renal cell carcinoma (RCC) has improved remarkably. However, not all patients have benefited fr...

Full description

Bibliographic Details
Main Authors: Ilaria Grazia Zizzari, Chiara Napoletano, Alessandra Di Filippo, Andrea Botticelli, Alain Gelibter, Fabio Calabrò, Ernesto Rossi, Giovanni Schinzari, Federica Urbano, Giulia Pomati, Simone Scagnoli, Aurelia Rughetti, Salvatore Caponnetto, Paolo Marchetti, Marianna Nuti
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Cancers
Subjects:
TKIs
mRCC
biomarkers
soluble factors
Online Access:https://www.mdpi.com/2072-6694/12/9/2620

Internet

https://www.mdpi.com/2072-6694/12/9/2620

Similar Items